Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2008
09/04/2008US20080213427 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides
09/04/2008US20080213245 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides; gene therapy
09/04/2008CA2679263A1 Sulfonamide compound
09/04/2008CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents
09/03/2008EP1964569A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
09/03/2008EP1964561A1 Inhibitors of IMPDH enzyme
09/03/2008EP1963313A2 Inhibitors of diacylglycerol acyltransferase (dgat)
09/03/2008EP1963312A1 Beta-secretase modulators and methods of use
09/03/2008EP1963303A2 Chemical compounds
09/03/2008EP1963289A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands
09/03/2008EP1963288A1 Substituted oxazole derivatives with an analgesic action
09/03/2008EP1963282A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
09/03/2008EP1963274A1 Benzoylpyrazole compounds and herbicides containing them
09/03/2008EP1963273A2 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitors
09/03/2008EP1963260A1 Process for the production of ezetimibe and intermediates used in this proces
09/03/2008EP1962852A2 Compounds, compositions and methods
09/03/2008EP1962838A2 Farnesoid x receptor agonists
09/03/2008EP1761497B1 Azadecalin glucocorticoid receptor modulators
09/03/2008EP1730112B1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
09/03/2008EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses
09/03/2008EP1311480B1 New amidino derivatives and their use as thrombin inhibitors
09/03/2008EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS
09/03/2008CN101258150A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
09/03/2008CN101258148A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
09/03/2008CN101258147A Derivatives of 4-piperazin-1-yl-4-benz0[B]thiophene suitable for the treatment of CNS disorders
09/03/2008CN101258131A 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
09/03/2008CN101255142A 2-substituted sulfinyl-5-(3,4,5-trialkoxy phenyl)-1,3,4-oxadiazole derivatives as well as preparation method and uses thereof
09/03/2008CN101255131A Heterocyclic derivatives as opioid modulators
09/03/2008CN100415737C Indole derivatives useful for treatment of CNS disorders
09/03/2008CN100415724C Pyrimidine derivatives
09/03/2008CN100415720C Quinoline derivative and quinazoline derivative, and medicinal composition containing the same
09/03/2008CN100415716C 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
09/02/2008US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
09/02/2008US7420062 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
09/02/2008US7420060 Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
09/02/2008US7420055 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide
09/02/2008US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/02/2008US7419999 Gamma lactams as prostaglandin agonists and use thereof
09/02/2008US7419991 Treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders
09/02/2008US7419990 e.g. benzyl {1-[2-(1-{[1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)-4,5-dimethylphenyl]propyl}carbamate; antidiabetic agent, obesity, sexual disfunctions
09/02/2008US7419984 for uses such as inhibiting the activity of lysophosphatidic acid acyltransferase beta and/or inhibiting the proliferation of a cell (e.g., tumor cell)
09/02/2008US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes
09/02/2008US7419975 Organic compounds
09/02/2008US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections
09/02/2008CA2411412C Indole derivatives useful for the treatment of cns disorders
09/02/2008CA2294351C Compounds useful for inhibition of farnesyl protein transferase
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
09/02/2008CA2248338C 2-amino-4-bicycloamino-1,3,5-triazines as herbicides and plant growth regulators
08/2008
08/28/2008WO2008103613A2 Hydroxylamine compounds and methods of their use
08/28/2008WO2008103353A1 Triazole compounds that modulate hsp90 activity
08/28/2008WO2008103351A2 Heterocyclic aspartyl protease inhibitors
08/28/2008WO2008102092A1 Furazane derivatives, preparation thereof and energetic compositions containing them
08/28/2008WO2008101995A1 Indole derivatives
08/28/2008WO2008070041A3 Inhibitors of akt activity
08/28/2008WO2007102769A3 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
08/28/2008WO2007087488A9 Indole sulfonamide modulators of progesterone receptors
08/28/2008WO2007072142A3 Benzimidazole-5-carboxamide derivatives
08/28/2008US20080207913 Etherification of biological active materials
08/28/2008US20080207708 Analgesics; antiinflammatory agents; bone disorders; neurodegenerative diseases
08/28/2008US20080207705 Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists
08/28/2008US20080207704 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists
08/28/2008US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes
08/28/2008US20080207685 Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar
08/28/2008US20080207641 Immunosuppressants; antiallergens
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/28/2008US20080207618 6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor
08/28/2008US20080207617 Prevent autophosphorylation of tyrosine kinase; therapy for hematopoietic cancer; leukemia; myelodysplastic syndrome
08/28/2008US20080207616 Anticancer agents; for humans, animals
08/28/2008US20080207614 Quinazoline derivatives for the treatment and prevention of diabetes and obesity
08/28/2008US20080207613 Selective Kinase Inhibitors
08/28/2008US20080207612 Analgesics; pain management
08/28/2008US20080207610 Aldh-2 inhibitors in the treatment of addiction
08/28/2008US20080207609 Anticancer agents; kinase inhibitor; immunotherapy; viricides; antiinflammatory agents
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008US20080207589 Cyclized derivatives as eg-5 inhibitors
08/28/2008US20080206312 Therapeutic Morpholino-Substituted Compounds
08/28/2008US20080206258 Novel Tetrahydropyridothiophenes
08/28/2008CA2679066A1 Hydroxylamine compounds and methods of their use
08/28/2008CA2678958A1 Heterocyclic aspartyl protease inhibitors
08/28/2008CA2678147A1 Indole derivatives
08/27/2008EP1961752A2 Piperidine Compounds
08/27/2008EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
08/27/2008EP1960392A2 Heterocycle-substituted 3-alkyl azetidine derivatives
08/27/2008EP1960376A1 Oxadiazole derivatives with crth2 receptor activity
08/27/2008EP1960370A1 Pyridiazinone derivatives for tumour treatment
08/27/2008EP1960363A2 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
08/27/2008EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
08/27/2008EP1959959A2 Morpholine carboxamide prokineticin receptor antagonists
08/27/2008EP1959951A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
08/27/2008EP1708996B1 Fused heteroyral derivatives for use as p38 kinase inhibitors
08/27/2008EP1620431B1 3-carbonylaminothiophenes and their use as fungicides
08/27/2008CN101253171A Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
08/27/2008CN101253167A Substituted imidazole compounds as KSP inhibitors
08/27/2008CN101253151A GPCR agonists
08/27/2008CN101252930A Isoquinoline compounds and methods of use thereof
08/27/2008CN101252929A G-protein coupled receptor agonists
08/27/2008CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same